Salivary gland extracts of the deerfly contain a potent inhibitor of platelet aggregation, which assists the insect in obtaining a blood meal. The extract prevents platelet aggregation induced by ADP, thrombin, and collagen and inhibits fibrinogen binding to the glycoprotein fib/Ma receptor on platelets. The active component in deerfly salivary gland extract appears to be a protein that is comparatively more potent than the disntegrins present in viper venoms. Isolation and characterization of this protein may provide different directions in therapeutics and studies of normal platelet physiology.
Hematophagous arthropods produce a number of bioactive compounds in their saliva that facilitate blood feeding by overcoming the normal hemostatic mechanisms of the host. Injury to the host's blood vessels triggers primary hemostasis. Owing to the fundamental role of the platelet response in primary hemostasis, it is reasonable to assume that hematophagous arthropods would evolve to secrete a platelet inhibitor in their saliva. Although a potent vasodilator has been isolated from the sand fly Lutzomyia longipalpis (1, 2) and inhibitors of blood coagulation factor Xa have been characterized from both the black fly Simulian vittatum (3) and the soft tick Ornithodora moubata (4, 5) , isolation of a direct platelet inhibitor from an arthropod has not been reported.
There have been a few reports of antiplatelet activity in the saliva of various arthropods, including apyrase activity in ticks (6) , mosquitoes (7), blood sucking bugs (8) , and tse-tse flies (9) , and prostacyclin activity in Ixodes dammini ticks (10) . However, these activities have not been well characterized, and it is not clear whether these or other activities are responsible for the platelet inhibitory activity.
We report that salivary gland extracts from the deerfly (genus Chrysops) completely and dose-dependently inhibit normal aggregation of human platelets. The Enzyme Assays. Apyrase activity was measured by the method of Battastini and colleagues (13) in a reaction medium containing 5 mM KCl, 1.5 mM CaCl2, 0.1 mM EDTA, 10 mM glucose, 225 mM sucrose, 45 mM Tris HCl buffer (pH 8.0), and 5 mM sodium azide in a final vol of 200 ,l. This reaction medium was preincubated for 10 min at 37°C with 10 ,4 of control potato apyrase enzyme or 10 ,4 of a DFE dilution.
The reaction was initiated by addition of 10 ,ul of ATP or ADP to a final concentration of 1.0 ,uM. After 1 hr, the reaction was stopped by addition of 200 ,ul of 10% trichloroacetic acid. Samples were chilled on ice for 10 min and then centrifuged; 50 ,ul of supernatant was removed for assay of inorganic phosphate. Because DFE was prepared in PBS, all dilutions of DFE and the blank were prepared in PBS as well.
Inorganic phosphate was measured by the method of Hess and Derr (14) . Briefly, 50 ,ul of sample was mixed with 800 Il4 of color reagent (0.03375% malachite green hydrochloride/ 1.05% molybdate/2% Sterox in 1 M HCl). After 1 min, 100 ,l4
of a 34% sodium citrate solution was added and mixed. The samples were incubated at room temperature for 30 min, after which absorbance was measured at 660 nm in a spectrophotometer (Beckman). Blanks contained water, color reagent, and citrate. All samples were run in triplicate. Adenylate kinase activity was measured by the method of Battastini and colleagues (13) platelets. After incubation, samples were precipitated with an equal volume of 10% trichloroacetic acid and the supernatants were extracted four times with water-saturated ether and lyophilized. The resultant pellet was resuspended in acetate buffer and the concentration of cAMP was determined with an RIA kit (New England Nuclear). Platelet cGMP levels were also measured with an RIA kit after incubation of PRP with three deerfly salivary gland equivalents. Biochemical Characterization of DFE. To determine whether platelet inhibitory activity was contained within the protein or nonprotein portion of DFE, ethanol precipitation of protein was performed by adding 10 vol of absolute ethanol to 10 gland equivalents in bovine serum albumin (1 mg/ml).
The mixture was kept at -20°C for 2 hr and then spun in a microcentrifuge for 10 min. Supematants and pellets were dried in a Speed-Vac, resuspended in 50 /l of PBS, and then assayed for inhibition of platelet aggregation induced by 5 uM ADP. Sensitivity to trypsin was tested by incubating five gland equivalents with the protease at a final concentration of 1 or 2 mg/ml in 50 /l of PBS for 30 min at 37°C. Soybean trypsin inhibitor was added to a final concentration of 2 mg/ml to stop the reaction. The reaction mixture was then assayed for inhibition of platelet aggregation induced by 5 uM ADP. Quantification of protein in DFE was performed according to the method of Lowry and colleagues (15) .
Gel Electrophoresis. Polyacrylamide gel electrophoresis was performed with the Phast System (Pharmacia) and proteins were visualized by silver staining.
RESULTS
Inhibition of ADP-Induced Platelet Aggregation. Two-thirds of a deerfly salivary gland equivalent, or 1.33 ,ug of total protein (see below), completely inhibited the aggregation of human platelets in 300 ,ul of PRP induced by thrombin (0.05 unit/ml) (Fig. 1) . Platelet aggregation induced by 10 ,uM ADP or collagen (20 p,g/ml) was also blocked by this final concentration of DFE in PRP (data not shown).
IC50 of DFE for 10 ,uM ADP-Induced Aggregation. To assess the potency of DFE, the extent of platelet aggregation was plotted for various concentrations of DFE, and an IC50 value of 0.24 gland equivalent per 300 Al of PRP, or 0.47 ,ug per 300 /l of PRP, was calculated (Fig. 2) .
Shift of the ADP-Induced Platelet Aggregation Curve. The extent of platelet aggregation induced by increasing amounts of ADP in the presence of a fixed concentration of DFE was determined. DFE shifts the ADP-induced platelet aggregation curve to the right and downward (Fig. 3) , suggestive of noncompetitive inhibition. Interestingly, the inhibitory effect of DFE cannot be overcome by concentrations of ADP up to 20 ,uM, the highest concentration tested.
Effect of DFE on 125I-Fibrinogen Binding to Platelets. Because the binding of fibrinogen to its receptor on the platelet surface is essential for aggregation responses to all agonists, we examined the effect of DFE on fibrinogen binding. DFE Apyrase Activity in DFE. Because others have shown that arthropod salivary gland extracts contain apyrase activity, we examined DFE for such activity. When the extract from 0.24 gland equivalent was tested, the amount that corresponds to the IC50 for 10 ,zM ADP-induced aggregation, no apyrase activity was found; however, activity was detected in the extract from 0.55 or more gland equivalent (Fig. 5) . The assay could detect <0.0035 unit of control apyrase, a subthreshhold amount of inhibitory enzyme. This amount of control enzyme released four times as much phosphate as was released by the extract from 0.55 salivary gland. These results suggest that apyrase is not the major inhibitor of ADP-induced platelet aggregation in DFE. The apyrase activity found with larger amounts of DFE could not be explained by the concerted action of an ATPase with an adenylate kinase because the latter activity was found to be negligible (data not shown).
Effect of DFE on Cyclic Nucleotide Levels. Many inhibitors of platelet activation such as prostaglandin E1, prostacyclin, adenosine, forskolin, and nitroglycerin act by raising the intracellular concentration of cAMP or cGMP. To determine whether DFE raises cAMP levels, platelets were incubated with or without DFE and concentrations of platelet cAMP were determined. Although a 600-fold increase in platelet cAMP was observed after incubation with prostaglandin E1, no change in cAMP levels was observed after incubation with DFE. In addition, no change in platelet cGMP levels was detected after incubation with DFE.
Characterization of DFE. DFE was subjected to a series of treatments followed by assay for ADP-induced platelet aggregation. After precipitation with 100%o ethanol, activity was recovered in the pellet but was absent in the supernatant, suggesting that the active component was a protein. Treat activity, consistent with the ethanol precipitation result. Quantification revealed that there was 2.0 ,ug of total protein per deerfly salivary gland. The proteins in DFE were separated by gel electrophoresis as shown in Fig. 6 . At least 15 bands ranging from 10 to 100 kDa are seen; that which represents the platelet inhibitor remains to be determined. As other reports have demonstrated apyrase activity in arthropod salivary gland extracts, we examined DFE for the presence of such activity. Although a small amount of apyrase activity was found, it was not sufficient to account for the antiplatelet activity of DFE. Perhaps the fibrinogen receptor antagonist in DFE may be relatively more important in blood feeding than the apyrase.
DISCUSSION
Although many known platelet inhibitors act by raising the levels of platelet cyclic nucleotides, our results indicate that DFE has no effect on levels of these second messengers.
Because insect salivary glands can store only limited amounts of protein, one would expect that a salivary antiplatelet protein would need to be very potent in order to overcome the host's hemostatic mechanisms. Isolation and characterization of the deerfly platelet inhibitor may provide an agent useful in medical therapeutics and could serve as a tool to elucidate further the normal mechanisms of platelet function and hemostasis.
